Clinical Study Delivery Lead, Global Clinical Operations, Oncology Therapy Area, R&D, Orion Corporation

The Clinical Study Delivery Lead provides global leadership for the planning, set up, execution, oversight, and delivery of complex oncology clinical trials from First in Human (FIH) through late phase Ph2/3 registration studies and submission. The role is responsible for driving study execution, ensuring high quality data, maintaining compliance with GCP/ICH, and managing cross functional and cross regional teams to achieve program goals within scope, budget, timelines, and quality standards. This role brings strong expertise in oncology clinical development studies, in immuno-oncology, biologics, targeted therapies, and solid tumor indications. Responsibilities Global Study Leadership: Lead the end to end execution of global Phase I–III oncology studies, including FIH and registration enabling trials, from startup through closeout, to ensure the study is delivered within timelines, budget and with high quality. Provide hands-on project leadership in a global, cross-functional setting, including study timelines projection, protocol development support, site selection/activation, vendor management, timeline/budget oversight, risk/issue resolution, and CRO performance management. Lead the study team and drive study execution through team collaboration, ensuring alignment across internal teams and external partners, and act as a self-starter in a fast-paced, resource-constrained environment. Study Execution & Oversight Plan, drive and oversee study start up, site activation, enrollment strategy, patient retention, data quality oversight, database readiness, study reporting and CSR delivery aligned with regulatory strategy submission plans. Ensure rigorous vendor oversight, particularly CRO performance (monitoring, data management, labs, imaging, ePRO, etc.).Proactively identify operational risks and implement robust mitigation plans. Escalate critical issues and propose solutions to senior leadership. Plan and manage study timelines, project site activation, recruitment and readout timelines, including building various scenarios depending on data-driven study outcome assumptions and other requirements. Manage clinical trial budgets, forecasting, accruals, and change orders. Ensure adherence to ICH GCP, local/global regulations, SOPs, and audit readiness, including respond to audits/inspections, and coordinate CAPA implementation, as needed. Cross Functional Leadership & External engagement Partner closely with internal and external stakeholders to deliver integrated milestones. Chair global study team meetings, drive team collaboration and ensure clear decision making and documentation. Build strong relationships with investigators, global KOLs, and academic partners as required. Leads patient engagement strategies throughout clinical trial design, start up, and execution to ensure patient centric study planning, enhance recruitment and retention, and incorporate patient insights into operational decision making This role is based in Cambridge (MA), US and reports to VP, Global Clinical Operations. What you can expect from us At Orion Pharma, your work impacts millions of lives around the world. With us, you get to work on challenges that matter and see the difference your work makes every day. We believe our people are the key to our success, which is why we invest in your continuous learning. Our innovative products are world-class, and we take sustainability and ethics seriously. Rooted in our Nordic heritage, we value teamwork, low hierarchies, and a culture where every voice is heard. We are builders of well-being and offer jobs with a clear purpose: helping people live their lives to the fullest. Please visit our website to find further information about our values and Orion as an employer: https://www.orionpharma.com/careers/working-with-us/ What are we looking for? Required Master's degree in a scientific discipline preferred (advanced degree favored); equivalent extensive experience considered (e.g., from nursing/monitoring background progressing to PM). 10+ years of clinical operations experience, with 5+ years leading global oncology studies. Proven leadership of early phase oncology trials, including FIH, dose escalation/expansion, safety monitoring, and DMC interactions. Experience with late phase, global registration directed trials, including operational planning for NDA/BLA/MAA submissions. Experience in immuno oncology, biologics and targeted therapies in solid tumor indications Demonstrated ability to manage global CROs, complex budgets, and multi vendor landscapes. Strong understanding of oncology drug development, adaptive design, biomarkers, imaging, safety reporting, and protocol complexities. Expertise in ICH GCP, global regulatory requirements, and inspection readiness. Strong team player, and team-driver mindset with excellent communication, negotiation, conflict resolution, and stakeholder management skills. Hands-on, pragmatic, solution-oriented approach, analytical skills, and ability to anticipate/resolve issues proactively. Ability to travel internationally as needed. Preferred Experience in small biotech and/or fast paced growth environments. How to apply Please send your application with the latest CV and cover letter by 26th of July, 2026. The expected annual salary range for this position is USD 140, 000–230,000 per year. Final compensation will depend on skills, experience, and job‑related qualifications. We typically review applications already during the application period and may start interviewing candidates before the application deadline. Therefore, we invite you to send your application as soon as possible. #LI-ORION Orion Pharma’s pharmaceutical innovations are created within its R&D organization. We employ around 400 top professionals in the field of drug discovery and development. We work globally: in Espoo and Turku in Finland, in Cambridge and Nottingham in England and in Cambridge, MA, US. Orion R&D and the Innovative Medicines business division are dedicated to making a transformation to become a global player in the pain and oncology therapy areas.